111 (YI) Net Income towards Common Stockholders (2017 - 2025)
111 (YI) reported Net Income towards Common Stockholders of -$2.3 million for Q4 2025, up 14.64% on a YoY basis from -$2.0 million in Q4 2024, and down 27.4% sequentially from -$1.8 million in Q3 2025.
111 (YI) Net Income towards Common Stockholders (2017 - 2025) Analysis & Trends
111 (YI) has 9 years of Net Income towards Common Stockholders data on file, last reported at -$2.3 million in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 14.64% year-over-year to -$2.3 million; the trailing twelve-month figure through Dec 2025 stood at -$9.3 million (down 3.42% YoY), and the FY2025 full-year result was -$9.5 million, down 7.03% from the prior year.
- Net Income towards Common Stockholders retreated to -$2.3 million in Q4 2025, from -$1.8 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$1.8 million in Q3 2025 to a low of -$39.2 million in Q3 2021.
- A 5-year average of -$11.9 million and a median of -$10.3 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders slumped 145.43% in 2021 and jumped 90.83% in 2024, its largest moves.
- Tracing YI's Net Income towards Common Stockholders over 5 years: stood at -$17.5 million in 2021, then rose by 5.05% to -$16.6 million in 2022, then tumbled by 78.6% to -$29.6 million in 2023, then jumped by 90.83% to -$2.7 million in 2024, then grew by 14.64% to -$2.3 million in 2025.
- Business Quant data shows YI's Net Income towards Common Stockholders at -$2.3 million in Q4 2025, -$1.8 million in Q3 2025, and -$2.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 1.86 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 1.63 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 380.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 112.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -2.32 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -9.08 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | -44,362.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -2.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.32 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -2.73 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | -2.72 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Jun 30, 2024 | -1.93 Mn |
| Mar 31, 2024 | -1.91 Mn |
| Dec 31, 2023 | -29.63 Mn |
| Sep 30, 2023 | -12.79 Mn |
| Jun 30, 2023 | -7.89 Mn |
| Mar 31, 2023 | -4.63 Mn |
| Dec 31, 2022 | -16.59 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -14.22 Mn |
| Mar 31, 2022 | -17.41 Mn |
| Dec 31, 2021 | -17.47 Mn |
| Sep 30, 2021 | -39.24 Mn |
| Jun 30, 2021 | -24.62 Mn |
| Mar 31, 2021 | -22.38 Mn |